Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing.
Why might this be a problem? Read more at https://news.bloomberglaw.com/ip-law/rush-for-generic-go-ahead-on-novel-drugs-roils-pharma-industry
